MSH Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
MSH Capital Advisors's LLY Position: Q3 2026 in Review
MSH Capital Advisors reduced its Eli Lilly (LLY) stake by 7.7% in Q3 2026, selling an estimated $153K and leaving 1,555 shares worth $1.8M. The position accounts for 0.28% of the portfolio, ranked #86.
MSH Capital Advisors first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $2.02M in Q2 2026. 3,740 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- MSH Capital Advisors held 1,555 shares of Eli Lilly worth $1.8M as of Q3 2026.
- MSH Capital Advisors sold 130 Eli Lilly shares in Q3 2026, an estimated $153K.
- Eli Lilly made up 0.28% of MSH Capital Advisors's portfolio in Q3 2026, its #86 holding.
- MSH Capital Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
- MSH Capital Advisors's Eli Lilly position peaked at $2.02M in Q2 2026.
- 3,740 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on MSH Capital Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.